Palo Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$2.52M Sell
38,445
-863
-2% -$64.4K 1.07% 37
2018
Q3
$3.09M Buy
39,308
+7,527
+24% +$538K 1.11% 34
2018
Q2
$2.04M Buy
31,781
+419
+1% +$27.6K 0.74% 52
2018
Q1
$1.95M Buy
31,362
+4,195
+15% +$301K 0.71% 54
2017
Q4
$1.97M Sell
27,167
-4,124
-13% -$300K 0.88% 47
2017
Q3
$2.54M Buy
31,291
+581
+2% +$46K 1.34% 26
2017
Q2
$2.47M Buy
30,710
+228
+0.7% +$18K 1.4% 23
2017
Q1
$2.39M Buy
30,482
+9,870
+48% +$788K 1.41% 21
2016
Q4
$1.63M Sell
20,612
-331
-2% -$26.8K 1.02% 43
2016
Q3
$1.86M Sell
20,943
-28,715
-58% -$2.71M 1.29% 23
2016
Q2
$4.75M Buy
49,658
+24,381
+96% +$2.43M 1.63% 6
2016
Q1
$2.62M Sell
25,277
-772
-3% -$75.1K 2.07% 4
2015
Q4
$2.55M Buy
26,049
+1,773
+7% +$174K 2.31% 4
2015
Q3
$2.34M Buy
24,276
+3,897
+19% +$410K 2.04% 5
2015
Q2
$2.14M Sell
20,379
-1,370
-6% -$140K 1.67% 5
2015
Q1
$2.23M Sell
21,749
-6,415
-23% -$649K 1.82% 7
2014
Q4
$2.71M Buy
+28,164
New +$2.48M 2.28% 1

Other funds holding CVS

Palo Capital's CVS Position: Q4 2018 in Review

Palo Capital reduced its CVS Health (CVS) stake by 2.2% in Q4 2018, selling an estimated $64.4K and leaving 38,445 shares worth $2.52M. The position accounts for 1.07% of the portfolio, ranked #37.

Palo Capital first reported a position in CVS in Q4 2014 and has held it in 17 quarters since. The position peaked at $4.75M in Q2 2016. 1,780 funds tracked by Wall St. Rank hold CVS as of Q4 2018.

  • Palo Capital held 38,445 shares of CVS Health worth $2.52M as of Q4 2018.
  • Palo Capital sold 863 CVS Health shares in Q4 2018, an estimated $64.4K.
  • CVS Health made up 1.07% of Palo Capital's portfolio in Q4 2018, its #37 holding.
  • Palo Capital first reported a position in CVS Health in Q4 2014 and has held it in 17 quarters since.
  • Palo Capital's CVS Health position peaked at $4.75M in Q2 2016.
  • 1,780 funds tracked by Wall St. Rank held CVS Health as of Q4 2018.

Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.